Loading...
Loading...
IQV| Name | Value |
|---|---|
| Revenues | 3,896.0M |
| Cost of Revenue | 2,518.0M |
| Gross Profit | 1,378.0M |
| Operating Expense | 800.0M |
| Operating I/L | 550.0M |
| Other Income/Expense | -201.0M |
| Interest Income | 13.0M |
| Pretax | 349.0M |
| Income Tax Expense | 65.0M |
| Net Income/Loss | 285.0M |
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry globally. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. It offers cloud-based applications, real world solutions, strategic consulting services, project management, clinical monitoring, virtual trials, laboratory services, and health care provider and patient engagement services. IQVIA serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies, generating revenue through the provision of these services and solutions.
